Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for InfuSystems Holdings, Inc. (INFU : AMEX)
 
 • Company Description   
InfuSystem is a rapidly growing healthcare services company that provides state-of-the-art electronic continuous ambulatory infusion pumps, supplies and support to oncology practices and clinics throughout the United States. More than 60% of oncologists across all 50 states turn to InfuSystem as their single, full-service source for cost-effective infusion pump management.

Number of Employees: 407

 
 • Price / Volume Information   
Yesterday's Closing Price: $8.58 Daily Weekly Monthly
20 Day Moving Average: 169,749 shares
Shares Outstanding: 20.54 (millions)
Market Capitalization: $176.23 (millions)
Beta: 1.23
52 Week High: $21.89
52 Week Low: $6.78
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 6.85% 16.61%
12 Week -22.21% -18.10%
Year To Date -49.62% -41.27%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
3851 West Hamlin Road
-
Rochester Hills,MI 48309
USA
ph: 248-291-1210
fax: 800-455-4338
None http://www.infusystem.com
 
 • General Corporate Information   
Officers
Richard DiIorio - Chief Executive Officer
Scott Shuda - Chairman
Carrie Lachance - President and Chief Operating Officer
Barry Steele - Chief Financial Officer
Paul Gendron - Director

Peer Information
InfuSystems Holdings, Inc. (BJCT)
InfuSystems Holdings, Inc. (CADMQ)
InfuSystems Holdings, Inc. (APNO)
InfuSystems Holdings, Inc. (UPDC)
InfuSystems Holdings, Inc. (IMTIQ)
InfuSystems Holdings, Inc. (CYGN)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 45685K102
SIC: 3841
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/11/22
Share - Related Items
Shares Outstanding: 20.54
Most Recent Split Date: (:1)
Beta: 1.23
Market Capitalization: $176.23 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: 0.00
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/11/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: 429.00
PEG Ratio: -
Price Ratios
Price/Book: 3.83
Price/Cash Flow: 10.94
Price / Sales: 1.68
EPS Growth
vs. Year Ago Period: -166.67%
vs. Previous Quarter: -200.00%
Sales Growth
vs. Year Ago Period: 9.40%
vs. Previous Quarter: 0.92%
ROE
03/31/22 - 0.84
12/31/21 - 3.11
09/30/21 - 26.77
ROA
03/31/22 - 0.40
12/31/21 - 1.50
09/30/21 - 12.37
Current Ratio
03/31/22 - 1.67
12/31/21 - 1.71
09/30/21 - 1.51
Quick Ratio
03/31/22 - 1.39
12/31/21 - 1.41
09/30/21 - 1.25
Operating Margin
03/31/22 - 0.37
12/31/21 - 1.39
09/30/21 - 11.64
Net Margin
03/31/22 - 0.37
12/31/21 - 1.39
09/30/21 - 11.64
Pre-Tax Margin
03/31/22 - -0.05
12/31/21 - 1.23
09/30/21 - 0.94
Book Value
03/31/22 - 2.24
12/31/21 - 2.34
09/30/21 - 2.26
Inventory Turnover
03/31/22 - 11.47
12/31/21 - 11.56
09/30/21 - 11.92
Debt-to-Equity
03/31/22 - 0.76
12/31/21 - 0.68
09/30/21 - 0.66
Debt-to-Capital
03/31/22 - 43.03
12/31/21 - 40.42
09/30/21 - 39.68
 

Powered by Zacks Investment Research ©